Daily Summary
The Supreme Court is set to hear a case that could allow states to restrict Medicaid funding for Planned Parenthood, potentially limiting reproductive healthcare access. American biologists Victor Ambros and Gary Ruvkun won the Nobel Prize for discovering how microRNAs regulate gene activity, a breakthrough that may lead to new treatments for diseases like cancer and heart disease. In other developments, the FDA approved exa-cel, the first CRISPR-based treatment for sickle cell disease, showing promising clinical results while highlighting the need for longer-term safety studies and addressing high costs.
Nobel Prize in Medicine Awarded for Breakthrough in microRNA Gene Regulation
American biologists Victor Ambros and Gary Ruvkun were awarded the Nobel Prize in Medicine for their pioneering research on microRNAs, challenging traditional views on gene regulation. Their discovery may unlock new approaches to treating diseases such as cancer and cardiovascular conditions.
FDA Approves First CRISPR-Based Treatment for Sickle Cell Disease
The FDA approved exa-cel, the first CRISPR-based treatment for sickle cell disease, which has shown effectiveness in preventing symptoms for at least one year. However, longer follow-up studies are needed to fully assess its long-term side effects and cost impacts.
Supreme Court to Hear Case on Medicaid Funding for Planned Parenthood
The Supreme Court is hearing a case on South Carolina's attempt to block Medicaid funding to Planned Parenthood, a decision that could limit access to essential healthcare services for many low-income patients.